Candidemia in patients with diabetes mellitus: Epidemiology and predictors of mortality

被引:26
作者
Bader, MS
Lai, SM
Kumar, V
Hinthorn, D
机构
[1] Univ Kansas, Med Ctr, Dept Prevent Med, Div Infect Dis, Kansas City, KS 66103 USA
[2] Kansas City VA Med Ctr, Div Infect Dis, Kansas City, MO USA
关键词
D O I
10.1080/00365540410021126
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Candidemia is the fourth most frequent nosocomial bloodstream infection in the US. The clinical characteristics and outcome of candidemia in adult patients with diabetes mellitus (DM) have not been reported in the literature. The objective of the study was to determine the epidemiology and determinants of mortality in diabetic patients with candidemia. A retrospective cohort study among diabetic patients with candidemia was carried out at 2 medical centers. The primary outcome was death from any cause after the onset of candidemia until discharge from the hospital. A stepwise logistic regression analysis was performed to determine the predictors of mortality. From June 1995 to June 2003, 87 patients with both DM and candidemia were studied. Candida albicans was the most common (48/87, 55%) and Candida glabrata the second most common isolate of candidemia (18/87, 21%). Overall hospital mortality was 39% (34/87). Logistic regression analysis identified 3 independent determinants of death; Apache II score greater than or equal to23 (OR 8.3, 95% CI{2.7, 25.4}, p = 0.0002), nosocomial candidemia (OR 10.2, 95% CI{1.1, 97.9}, p = 0.04), and mechanical ventilation (OR 3.6, 95% CI{1.1, 11.2}, p = 0.03). The study demonstrates the emergence of non-albicans species of Candida as major causes of candidemia among diabetic patients. The severity of illness reflected by Apache II was the most significant predictor of mortality among diabetic patients with candidemia.
引用
收藏
页码:860 / 864
页数:5
相关论文
共 21 条
[1]   Candidemia in a tertiary care cancer center - In vitro susceptibility and its association with outcome of initial antifungal therapy [J].
Antoniadou, A ;
Torres, HA ;
Lewis, RE ;
Thornby, J ;
Bodey, GP ;
Tarrand, JJ ;
Han, XY ;
Rolston, KVI ;
Safdar, A ;
Raad, II ;
Kontoyiannis, DP .
MEDICINE, 2003, 82 (05) :309-321
[2]  
CALVET H, 2001, INFECT DIS CLIN, V15, P78
[3]   Association of hyperglycemia with increased mortality after severe burn injury [J].
Gore, DC ;
Chinkes, D ;
Heggers, J ;
Herndon, DN ;
Wolf, SE ;
Desai, M .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2001, 51 (03) :540-544
[4]   Attributable mortality of nosocomial candidemia, revisited [J].
Gudlaugsson, O ;
Gillespie, S ;
Lee, K ;
Berg, JV ;
Hu, JF ;
Messer, S ;
Herwaldt, L ;
Pfaller, M ;
Diekema, D .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (09) :1172-1177
[5]   HANDICAPS TO HOST DEFENSE - EFFECTS OF HYPERGLYCEMIA ON C3 AND CANDIDA-ALBICANS [J].
HOSTETTER, MK .
DIABETES, 1990, 39 (03) :271-275
[6]   The epidemiology of candidemia in two United States cities: Results of a population-based active surveillance [J].
Kao, AS ;
Brandt, ME ;
Pruitt, WR ;
Conn, LA ;
Perkins, BA ;
Stephens, DS ;
Baughman, WS ;
Reingold, AL ;
Rothrock, GA ;
Pfaller, MA ;
Pinner, RW ;
Hajjeh, RA .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) :1164-1170
[7]   Fungal and parasitic infections of the eye [J].
Klotz, SA ;
Penn, CC ;
Negvesky, GJ ;
Butrus, SI .
CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (04) :662-+
[8]  
LIBSEN J, 2003, MEDICINE, V82, P187
[9]  
LIPOVSKY M, 2000, INFECT DIS
[10]   Comparison of caspofungin and amphotericin B for invasive candidiasis. [J].
Mora-Duarte, J ;
Betts, R ;
Rotstein, C ;
Colombo, AL ;
Thompson-Moya, L ;
Smietana, J ;
Lupinacci, R ;
Sable, C ;
Kartsonis, N ;
Perfect, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :2020-2029